Dr. Milad Alucozai is a biotech executive, computational neuroscientist, founder, and investor dedicated to translating frontier science into scalable platforms that advance human health. Recognized by Business Insider as one of the top 100 early-stage investors, he co-founded Pamir Ventures with Roger Ferguson, former Vice Chair of the U.S. Federal Reserve, to serve as the first check and full-stack partner to technical pioneers redefining markets. He also serves as an External Advisor to Amgen. Across his career, he has helped companies raise hundreds of millions in venture capital and supported billions in startup-pharma partnerships and co-development deals.

He supported $1.5 billion in ARPA-H funding and previously advised AstraZeneca. He is the creator of the BITS (Bio-Industrial Technology Stack) framework, which reframes biology as a geopolitical and industrial asset. A National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine, Dr. Alucozai graduated Phi Beta Kappa in Neuroscience from Purdue's Honors Program, earned a master's in Immunology and Public Health as a US-Ireland Alliance Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. He completed a Visiting Scholar appointment at the Wyss Institute for Biologically Inspired Engineering at Harvard University.